| 发明名称 |
HETEROCYCLIC COMPOUNDS AND USE THEREOF AS MODULATORS OF TYPE III RECEPTOR TYROSINE KINASES |
| 摘要 |
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions. |
| 申请公布号 |
SI2766359(T1) |
申请公布日期 |
2016.09.30 |
| 申请号 |
SI20120030628 |
申请日期 |
2012.10.12 |
| 申请人 |
Ambit Biosciences Corporation |
发明人 |
HADD Michael J.;HOCKER Michael D.;HOLLADAY Mark W.;LIU Gang;ROWBOTTOM Martin W.;XU Shimin |
| 分类号 |
|
主分类号 |
|
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
